Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse

NCT00946985 is registered in ClinicalTrials.gov with Ortho-McNeil Janssen Scientific Affairs, LLC as lead sponsor.

NCT NCT00946985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00946985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Active-controlled, Rater-blinded Study of the Prevention of Relapse Comparing Paliperidone Palmitate With Oral Risperidone in Adults With Recently-Diagnosed Schizophrenia Who Are at High Risk of Relapse
Lead sponsor
Ortho-McNeil Janssen Scientific Affairs, LLC
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2009
Completion date
March 31, 2010
Enrollment
163 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia